Due to advances in caring for critically ill children and those with chronic diseases, rates of
deep vein thrombosis (DVT) are increasing in children. Risk factors consist of central venous …

Neonates are the pediatric population at highest risk for development of venous
thromboembolism (VTE), and the incidence of VTE in the neonatal population is increasing …

This open-label, single-arm, prospective cohort trial is the first phase 3 safety study to
describe outcomes in children treated with dabigatran etexilate for secondary venous …

Thromboembolism is a serious complication of induction therapy for childhood acute
lymphoblastic leukemia. We prospectively compared the efficacy and safety of …

Pediatric lower extremity deep vein thrombosis (LE-DVT) can lead to postthrombotic
syndrome (PTS) and other adverse events. We investigated the outcomes of LE-DVT in …

Our understanding of postthrombotic syndrome (PTS) predictors in children is evolving. The
present study aimed to investigate differences in patient-and deep vein thrombosis (DVT) …

Background Predicting recurrent venous thromboembolic events (VTEs) is challenging in
clinical practice for both adults and children, but it is relevant for clinical management …

Background Pediatric trauma patients are at high risk for development of venous
thromboembolism (VTE). Our objective is to describe incidence, risk factors, and timing of …

Background Accurate prediction of the individual risk of venous thromboembolism (VTE)
remains suboptimal in children, and biomarkers are currently not used to stratify the risk of …

There are conflicting data about whether the development of cancer‐associated thrombo‐
embolism (TE) negatively impacts survival in children. The objective was to determine …